As it concerns events downstream the ß-catenin/LEF1 interaction, nuclear c-Myc expression was positive already in IBD and at the early stages of neoplastic transformation and was lost between IS and K, while Cyclin-D1 expression characterized the later stages of in situ and, even more, advanced carcinoma. The gene discussed is MYC; the disease is inflammatory bowel disease.